Jackson, A. M., Jhund, P. S., Anand, I. S., Düngen, H., Lam, C. S. P., Lefkowitz, M. P., Linssen, G., Lund, L. H., Maggioni, A. P., Pfeffer, M. A., Rouleau, J. L., Saraiva, J. F. K., Senni, M., Vardeny, O., Wijkman, M. O., Yilmaz, M. B., Saito, Y., Zile, M. R., Solomon, S. D., & McMurray, J. J. V. (2021). sacubitril–valsartan as a treatment for apparent resistant hypertension in patients with heart failure and preserved ejection fraction. European heart journal, 42, 3741–3752. http://access.bl.uk/ark:/81055/vdc_100142223011.0x000052